AI showdown: which bot helps doctors diagnose better?
NCT ID NCT07037940
First seen Jun 25, 2026 · Last updated Aug 12, 2026 · Updated 3 times
Summary
This study tested two AI tools—OpenEvidence and GPT-4 (ChatGPT)—to see which one helps doctors make better diagnoses and treatment decisions. Twenty-seven internal medicine doctors used both tools on medical cases. The goal was to compare how accurate and fast each AI made them. Results are still being analyzed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE LANGUAGE MODELS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harvard Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
MontefioreMC
The Bronx, New York, 10467, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- AI that asks questions first may help people triage symptoms more accurately
- AI tutor for kidney doctors: can a chatbot improve dialysis decisions?
- AI assistant could help junior doctors plan lung cancer surgeries
- AI vs doctors: who makes better dialysis decisions?
- AI Co-Pilot aims to sharpen eye disease diagnoses